SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start

level: Level 3

Questions and Answers List

Digitalization and maintenance dosage

level questions: Level 3

QuestionAnswer
When there is no urgency, an oral digitalizing dose is first administered maintenance dose is adjusted on the basis of clinical and lab assessment. a steady-state level is achieved in 5 half-lives (about 8 days). __ can be admin IV over a period of several min to obtain rapid digitalization The onset of action is within 5-30 minutes; the maximal effect is reached within 1-5 hours.Digoxin
The total oral loading dose is divided into doses given every 6 hours and admin over the course of 36-48 hours. The maximal effect of a dose of digitoxin is reached approx 9 hours after oral administration.Digitoxin
Adverse effects of Digitalis glycosides1 Low margin of safety - intoxication from overdosing is a potential fatal problem, lethal dose is likely to be only 5-10 times the minimal effective dose. 2 Intoxication is frequently precipitated by depletion of serum K+ due to diuretic therapy & may also occur as a result of: 1 Prolonged administration of corticosteroids 2 Protracted vomiting and diarrhea
Digitalis glycosides Signs of toxicity:Anorexia (often the earliest sign) Nausea, vomiting, and diarrhea Headache, fatigue, malaise, neuralgias, and delirium Vision changes, including abnormal color perception Cardiac effects: premature ventricular contractions (PVCs) and ventricular tachycardia and fibrillation; A-V dissociation and block; sinus arrhythmia and S-A block
Treatment of digitalis toxicity1 KCl is administered orally or by slow, careful IV infusion if hypokalemia is present; K+ is NOT given if severe A-V block is found or if serum K+ levels are high. 2 magnesium replacement 3 Phenytoin can be given for ventricular and atrial arrhythmias 4 Lidocaine and procainamide can be used to treat ventricular arrhythmias 5 cholestyramine binds to cardiac glycosides and has been used to hasten their elimination
NO donors which activate soluble guanylate cyclase in vascular smooth muscle cells to relax them Rapid acting nitroglycerine tablets or spray (sublingual) Short acting oral agents like isosorbide dinitrate Long acting oral agents like isosorbide mononitrate Topical like transdermal patches, ointments of nitroglycerine I.V. like nitroglycerineNitrosovasodilators
Direct acting vasodilator, MOA is not known Reduces both right and left ventricular afterload by reducing pulmonary and systemic vascular resistance Results in increased cardiac output and decreased ventricular wall stress during systole Reduces renal vascular resistance and increases renal blood flow more than any other vasodilator except ACE inhibitors Preferred drug in CHF (ACE intolerant) with renal impairment is more often used in combination with isosorbide dinitrateHydralazine
are being used as FIRST-LINE AGENT FOR CONGESTIVE HEART FAILURE.captopril and enalapril
Adverse effects captopril and enalaprilSevere persistent cough occasionally occurs Hypotension and deterioration of renal function can occur with an ACEI-diuretic combination. A/E associated with captopril such as rash, taste disturbances, proteinuria, and leukopenia, may be related to the sulfhydryl moiety of captopril
Introduced recently for treatment of CHF Recombinant form of human natriuretic peptide Naturally secreted by the ventricles, increases cGMP in vascular smooth muscles and reduces arteriolar and venous tone Causes natriuresis, short t½ of 18 min Administered as bolus dose 2 µg/kg i.v. followed by continuous i.v.infusion of 0.01 to 0.03 µg/kg/min Used in acute decompensated heart failure associated with dyspnoea at rest ADR: hypotensionNesiritide